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ABSTRACT 
Androgen Receptor Formation in Prenatally Endocrine Disrupted Mice. (May 2014) 
Conor David Irwin 
Department of Health and Kinesiology 
Texas A&M University 
 
Research Advisor: Dr. Timothy Lightfoot 
Department of Health and Kinesiology 
 
Inactivity is one of the largest detriments in our society today. It has been estimated that about 
$434 billion are spent on inactivity related health problems in the United States per year (1). This 
dollar amount is only exceeded in gravity by the death toll, with more than 250,000 deaths per 
year directly attributing to physical activity (2). These alarming statistics have directed our lab 
into researching genetic factors contributing to physical activity. A current proposed mechanism 
contributing to physical activity suggests that androgen receptors are key mediators in activity 
regulation (3,4). Current literature suggests that certain chemicals, like Benzyl butyl phthalate 
(BBP), disrupts androgen receptor formation prenatally (5, 6) and we are hypothesizing that this 
androgen receptor malformation may decrease physical activity after birth. Therefore, the 
purpose of this study is to explore the relationship between endocrine disruptors given prenatally, 
androgen receptor formation, and physical activity. 
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CHAPTER I 
INTRODUCTION 
 
Physical activity has been a subject of interest in recent American culture. It seems everyone 
from Oprah Winfrey to Michelle Obama have something to say about America’s need for, or 
lack of, physical activity. With the advent of new leisure technology and the increase in white-
collar jobs the importance of physical activity has been diminished. This decline in physical 
activity has been matched with campaigns such as Michelle Obama’s Let’s Move campaign or 
the National Football League’s NFL Play 60 initiative. These campaigns have been created in 
order to raise awareness for the need of physical activity in Americans’, especially young 
Americans’, daily lives. While these initiatives are a great start, the need for additional measures 
still exists. As stated earlier, physical inactivity contributes to 250,000 deaths and about $434 
billion in expenses per year (1,2). The statistics are alarming and have been some of the major 
reasons for research aiming to understand the factors contributing to physical activity.  Physical 
activity is an extremely complex phenomena controlled by a variety of factors.  Among these 
factors are genetic controls with recent research showing that physical activity has a significant 
genetic regulation and that predisposition to a particular activity level can be an inherited trait 
(2).  At this time, it is still not clear which genetic/biological mechanisms are primary controllers 
of physical activity. It has been shown that sex hormones are a potential causative mechanism for 
physical activity and that supplementation of both male and female animals with testosterone 
while blocking estrogenic pathways, significantly increases physical activity (3,4).  This work, 
along with other research, strongly suggests that androgen receptors – the receptors that 
testosterone interacts with in the body – may be mediators of physical activity.  
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Distressingly, it has also been discovered that common environmental chemicals such as Benzyl 
butyl phthalate (BBP), which is common in consumer rubber products, can act as endocrine 
disruptors and can disrupt the sex hormone pathways, especially in prenatal conditions (5,6). 
While this research has shown that these hormones have an effect on humans, the gravity of that 
effect has yet to be understood.  Therefore, the purpose of this study was to determine if the 
administration of BBP to pregnant mice, will decrease androgen receptor formation in the 
resulting offspring. 
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CHAPTER II 
METHODS 
 
Sample Collection 
The mice used as breeder pairs in this study were inbred C57Bl/6J mice (Jackson Laboratories, 
Bar Harbor, ME).  Four breeder pairs of C57Bl/6J mice were purchased from Jackson 
Laboratories and were mated.  At confirmation of pregnancy (appearance of vaginal plug), the 
male mice were removed from the cage.  Beginning at nine days of pregnancy, the treatment 
pregnant mice were given interperioteneal injections of BBP (500 mg/kg) until day 16 of 
gestation.  The control mice were injected with an equal volume of saline from days 9-16 of 
gestation.  The resulting offspring (n=6, males=4, females=2) were weaned at 21 days of age, 
and housed individually with a running wheel at 4 weeks of age.  The mice were sacrificed at 10 
weeks of age by anesthetizing using vaporized isoflurane followed by cervical dislocation. The 
soleus (slow twitch skeletal muscle) was removed and flash-frozen for later analysis (7).  All 
procedures in this project were part of a larger project approved by the Texas A&M Institutional 
Animal Control and Use Committee (approval 2012-0274). 
 
Protein Extraction 
To determine whether the prenatal exposure to BBP had altered androgen receptor formation, we 
conducted western blot analyses in the soleus tissue.  The first step in the process was to extract 
the androgen receptor protein.  To do this Dangott Lysis Buffer was made and 500 µl of buffer 
was then added to a chosen sample  (<100 µg) in a labeled 1.7 ml tube. If sample was greater 
than 100 µg, 1000 µl of the buffer was added in combination with the sample. A mortar and 
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pestle, which had been previously placed in the freezer, was removed and a small amount of 
liquid nitrogen was added to the mortar. The sample was added and ground until it was a fine 
powder. Using an autoclaved spatula the sample was placed into the previously made 1.7 ml tube 
containing the buffer solution. The sample was placed on ice for 1 hour with intermittent bouts 
of vortexing every 15 minutes. The sample was then centrifuged for 30 minutes and 4 ºC. After 
centrifuging, the supernatant (protein) was removed and placed into newly labeled tubes. These 
tubes were placed in -20 ºC freezer for later analysis. 
 
Protein Concentration 
The concentration of androgen receptor protein – needed for loading the proper amount of 
sample into the western blotting - was determined using the Bradford Protein assay. Using a 96 
well plate, 300 µl of coomassie brilliant blue was pipetted into (7) wells. Five additional wells 
were added for the five different standard Bovine Serum Albumin concentrations (2000 µg/ml, 
1000 µg/ml, 500 µg/ml, 250 µg/ml, 125 µg/ml). A dilution series was made for each sample 
using Neat, 2X, 4X, 8X, and 16X dilutions. Ten µl of the sample, dilutions, and standards were 
added to the wells containing the 300 µl of coomassie. A blue color change was observed. The 
Nanodrop spectrophotometer (ThermoScientific, MA) and Bradford software were used with 2 
µl of each sample to determine the protein concentration. 
 
Western Blot 
Determining the actual amount of androgen receptor protein was done using a standard western 
blot technique.  Briefly, the glass and aluminum plates (as well as the black spacers) that make 
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up the gel caster were placed on a clean surface. After they were spread out they were sprayed 
with 100% methanol and wiped dry with a lab tissue. 
 
The black spacers were then inserted on the sides of the plates. Each gel plate pair was then 
inserted in the gel stand vertically. The plastic screws were then screwed in their respective holes 
to hold the plates in place. A gel seal was then added to the exposed corners in order to create a 
tight vacuum. The gel stand was then placed in the gel caster unit. Clamps were then placed on 
each side of the unit including the top of the gel plate and aluminum backing plate. 
 
Next a running gel and a stacking gel were made using a pre-prepared mixture to form the 
agarose gel matrix. The running gel was then added between the gel surfaces using a pipette to a 
point approximately ¾ the height of the plate surface. In order to flatten the gel uniformly water 
saturated isobutanol was added to fill the remaining ¼ of the space. The gel was left to harden 
overnight. After it had hardened the isobutanol was poured off and the gel was washed with 
distilled water. The stacking gel was pipetted in between the two plates all the way to the top 
(remaining ¼). 
 
After the running gel solidified and the stacking gel was poured, a 10 well comb was placed in 
between the plates in the stacking gel portion of the plate. After the gel had hardened the comb 
was removed and the wells were washed with distilled water. 
 
Each sample was then prepared using a precise ratio of distilled water and Laemmli buffer. The 
sample was vortexed and incubated at 90 ºC for 12 minutes. After each sample was prepared the 
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gel plates were clipped to the buffer chamber. The buffer chamber was filled with “electroblot” 
buffer and each sample well was filled with its corresponding sample. The buffer chamber was 
then connected to a 25 mA current at constant voltage. 
 
After the protein marker (blue line) reached the bottom of the gel plates the PVDF 
(polyvinylidene difluoride) membrane was sprayed with methanol and placed in a plastic 
container containing transfer buffer. Next, the gel was removed and placed in another plastic 
container with transfer buffer. The gel and membranes were then rocked for 20 minutes. 
Following this, two sponges and four pieces of filter paper were dipped in transfer buffer. The 
gel and the membrane were then placed very carefully in between these items with two sponges 
and two pieces of filter paper on each side (fig. 1). The product was then clamped and placed in 
the blotting chamber. 
Fig 1 
The chamber was then filled with transfer buffer. In order to allow a constant flow of buffer a stir 
bar was added. The chamber was connected to a 100 mA current at constant voltage for two and 
a half hours. 
  
After the two and a half hours, the membrane was removed and placed in a plastic container 
containing blocking buffer. The membrane was rocked for an hour followed by three separate 
bouts of washing with TBS (tris-buffered saline) for five minutes. 
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Antibodies were applied using a dilution of 1:500 (if sample greater than 40 µg) or 1:250 (if less 
than 40 µg). A plastic pouch was made with the gel sheet inside. Primary anitbodies were then 
pipetted into the pouch. The pouch was then sealed and rocked for a few minutes and left in the 
0°C refrigerator overnight. 
 
The pouches were removed and the samples washed in TBS using the same procedure as stated 
previously. The secondary antibody was then prepared using a ratio of 1:2000 (if sample greater 
than 40 µg) or 1:1000 (if less than 40 µg).  Five mL of blocking buffer was added along with the 
dilution of secondary antibody and pipetted into pre-made plastic pouches. These pouches were 
then sealed and incubated for one hour on the rocker. The samples were removed and washed 
with TBS using the same procedure as stated above. Using the West Pico Kit 
(chemiluminescence), 7 mL of liquid from both bottles were pipetted onto the membrane.  
 
The membrane was transferred to a plastic sheet and set inside the flourchem chamber (model 
and manufacturer name, city). The program (which program?) was turned on and the on-screen 
instructions were followed with the final outputs being a captured image of the blots and a 
measurement of optical density of each blot.  
 
Optical densities of all blots were compared between groups using ANOVA with treatment 
(BBP-prenatally or saline-prenatally).  Significance was set at p<0.05 a priori.  
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CHAPTER III 
RESULTS 
 
Due to difficulties with the western blotting, at the time of this writing, samples from only a 
subset of the experimental animals had been completed (we anticipate completion of all samples 
by 4/30/14).  In this subset, androgen receptor expression was not different between groups 
(Figure 2).  While not in the scope of this project, our results were supported by the lack of 
difference in physical activity observed between the treatment groups (Figures 3 and 4).  Males 
did not demonstrate a change in activity between treatment groups (p=0.9493; Figure 3), nor did 
the females (p=0.7235; Figure 4).   
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Figure 2:  Band optical density comparing BBP vs control groups (and male and female within each group) These results 
are limited due to the small samples sizes completed at the time of this document completion. 
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Figure 3: Activity data in males indicating no difference in running wheel distance throughout the study (p=0.9394). 
 
 
Figure 4: Activity data in females indicating no difference in running wheel distance throughout the study ((p=0.7235). 
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Chapter IV 
DISCUSSION 
 
This study’s purpose was to determine if BBP administered prenatally would alter the formation 
of androgen receptors.  Given the currently available results, BBP exposure did not affect 
androgen receptor formation in either male or female inbred mice.  We had hypothesized that if 
androgen receptor function was inhibited by prenatal exposure to BBP, then this might result in 
an alteration of physical activity control.  While not within the scope of the current project, our 
results were also supported by the observation of no alteration of physical activity levels in the 
subset of groups studied.  However, we are hesitant to conclude that androgen receptor formation 
was not inhibited by BBP because of the small initial subset we have completed at this time.  We 
anticipated that all data will be completed and analyzed within the next 30 days and will add to 
our story of how endocrine disruption affects androgen receptor formation and ultimately, 
physical activity.  If our data continue to conclude that androgen receptor disruption was not 
achieved, other alternative methods of endocrine disruption must be considered to determine the 
role of androgen receptors in controlling physical activity. 
Initially the dosage and administration of BBP must be analyzed. The dosage in the current 
literature suggests a 500 mg/kg concentration of BBP to be a harmful dosage in mice (11). 
Furthermore it has been shown that Bisphenol A (BPA), another endocrine disrupting compound, 
has been shown to be a marker of mammary cancer risk in mice given at a concentration of only 
5 mg/kg given through an intraperitoneal injection into the pregnant mothers (12). This 
successful protocol lead us to give intraperitoneal injections of BBP. Compared to a paper by 
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Clewell, et al., which gave an oral givage, our protocol differed from the current BBP literature 
(11). This difference could explain the lack of substantial evidence for endocrine disruption.   
If borne out in our completed dataset, the findings in this study question whether BBP actually 
exerts anti-androgenic effects.  There has been controversy in the endocrine disruptor literature 
as to whether these substances have physiological-altering properties or even pose health risks. 
According to Witorsch, et al., BBP, even when present, is at too low a concentration to 
significantly pose any real adverse androgen effects in humans (13). This would suggest that 
although BBP present at high doses does pose a risk for developing androgen related disorders, 
the concentrations needed to produce these results are far from the actual concentrations 
encountered in daily living. Based upon our extremely limited analysis at this time BBP does not 
indicate a significant effect on the androgen receptors.   
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